- CXR: especially if air transfer (usually normal at baseline)
- Blood gas: co-oximetry (carboxyhaemoglobin), lactate, PaCO2, PaO2
Resuscitation:
- Prevent ongoing burn injury
- Increase calculated fluid requirements if inhalation and burn injury present
We asked you in January to update to v4.7.2. After the deployment planned for 27th February, this new update will be needed to ensure that you are able to download RDS toolkits even when the RDS website is not available. We will wait until as many users as possible have downloaded the new version before switching off the old system for app downloads and moving entirely to the new approach.
To check your current RDS version, click on the three dots bottom right of the RDS app screen. This takes you to a “More” page where you will see the version number.
To update to the latest release:
On iPhones – go to the Apple store, click on your profile icon top right, scroll down to see the apps waiting to be updated and update the RDS app.
On Android phones – these can vary, but try going to the Google Play store, click on your profile icon top right, click on “Manage apps and device”, select and update the RDS app.
Welcome to the February 2025 update from the RDS team
A new release of RDS is planned (subject to outcomes of current testing) for week beginning 24th February. This will deliver:
The release will also incorporate a number of small fixes, including:
We will let you know when the date and time for the new release are confirmed.
There is now the capability to publish toolkits on the web with left hand side navigation rather than tiles on the homepage. To use this feature, turn on the “Toggle navigation panel” option at the top of the Page settings menu at toolkit homepage level – see below. Please note that publication to downloadable mobile app for this type of navigation is still under development.
The Benzodiazepine tapering tool (https://rightdecisions.scot.nhs.uk/benzotapering) is now available as part of the RDS toolkit for the national benzodiazepine prescribing guidance developed by the Scottish Government Effective Prescribing team. The tool uses this national guidance developed with a wide-ranging multidisciplinary group. This should be used in combination with professional judgement and an understanding of the needs of the individual patient.
Due to the intensive work Tactuum has had to undertake on the new technology infrastructure has pushed back the delivery dates again and some new requirements have come out of the recent user acceptance testing. It now looks likely to be an April release for the search and browse interface. The archiving and version control functionality may be released earlier. We’ll keep you posted.
At the end of January, Olivia completed the generation of the latest set of usage statistics for all RDS toolkits. If you would like a copy of the stats for your toolkit, please contact Olivia.graham@nhs.scot .
We have now generated reports of all RDS toolkit content that has exceeded its review date by 6 months or more. We will be in touch later this month with toolkit owners and editors to agree the plan for updating or withdrawing out of date content.
Some important toolkits in development by the RDS team include:
The RDS team and other information scientists in HIS have also been producing evidence summaries for the Scottish Government Realistic Medicine team, to inform development of national guidance around Procedures of Limited Clinical Value. This guidance will in due course be translated into an RDS toolkit.
To book a place, please contact Olivia.graham@nhs.scot, providing your name, organisation, job role, and level of experience with RDS editing (none, a little, moderate, extensive.)
To invite colleagues to sign up to receive this newsletter, please signpost them to the registration form - also available in End-user and Provider sections of the RDS Learning and Support area. If you have any questions about the content of this newsletter, please contact his.decisionsupport@nhs.scot If you would prefer not to receive future newsletters, please email Olivia.graham@nhs.scot and ask to be removed from the circulation list.
With kind regards
Right Decision Service team
Healthcare Improvement Scotland
This guidance has been developed to assist in the management of children that have suffered a burn to their airway and/or suffered smoke inhalation injuries.
This guidance should be used by the multidisciplinary team caring for children that have suffered an airway burn or smoke inhalation.
A multidisciplinary team should provide the management of the child with inhalation injury. Childhood inhalation injury mandates transfer to a PICU and if associated with burns to a paediatric burns centre.
There is insufficient data to support a treatment standard or a treatment guideline for the diagnosis of inhalation injury.
Suspect inhalation injury if:
Consultant anaesthetic staff/ PICU staff must be informed of all inhalation injuries.
Resuscitation:
No factors accurately and consistently predict the need for intubation. It is a clinical decision, ie not based on laboratory data. Drooling, stridor, hoarseness, facial or neck burn or increased work of breathing mandate intubation.
Children with lower airway injury that have required intubation should be managed in a PICU. It is possible that a child has deteriorated as lower airway injury has progressed, requiring intubation after a period of observation. These children should be referred to a PICU.
Injury may not manifest until after 48 hours. Toxins produce bronchospasm, mucosal oedema, microvascular hyperpermeability, obstructive airway casts and surfactant dysfunction.
Depressed epithelial integrity, loss of the mucocilairy clearance mechanism, migration of upper airway secretions to the lower airway and immuno-compromise predispose to bacterial colonization and translocation. Lower airway injury may progress to the acute respiratory distress syndrome. Strategies should be targeted to minimize iatrogenic ventilator induced lung injury. Intubation is as per upper airway thermal injury. (Suxamethonium can be used to facilitate intubation in the absence of a cutaneous burn injury. If there is a burn injury present then Suxamethonium can be used in the first 24 hours. Its use is contraindicated after 24 hours from a cutaneous burn).
The requirement for invasive lines can be discussed with the retrieval team. The retrieval team can site lines as indicated if the referring hospital are unable to gain access.
Cyanide toxicity is uncommon. Cyanide levels are not routinely performed by hospital biochemistry services, and have to be sent to reference laboratories. For this reason they cannot be used to influence management. The routine use of antidotes is not recommended as they have significant side effects. Priority should be given to stabilising the airway. The use of Cyanide antidotes should be discussed with a PICU consultant. Therapy will be influenced by local availability of antidotes.
Suspect Cyanide poisoning if
It is expected that the child will already be on a PICU. Bronchoscopy should not be performed by the referring hospital unless it is to assist an emergency intubation, or because the child cannot be ventilated after being intubated.
These patients are at risk of ARDS and iatrogenic ventilator induced lung injury. The standard of care for mechanical ventilation in inhalation injury has not been established. Local protocols for ventilating a patient with Acute Lung Injury should be adhered to these will be dependant on ventilator modes available. Lung protective strategies should be adopted. Any child requiring ventilation should be discussed with PICU pending transfer.
There is animal model evidence for the use of nebulised heparin and nebulised N-acetylcysteine. Whilst it is standard practice insome paediatric burn’s centres, its routine use cannot be recommended. The Shriner’s Bronchial Toilet Schedule is presented below.
The following is the Shriners policy, which can be adopted at the discretion of the PICU consultant.